-
公开(公告)号:NO930817D0
公开(公告)日:1993-03-05
申请号:NO930817
申请日:1993-03-05
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER , HENNING RAINER , WAGNER ADALBERT , GERHARDS HERMANN , BECKER REINHARD , SCHOELKENS BERNWARD
IPC: A61K31/4164 , A61K31/415 , A61K31/64 , A61P9/10 , A61P9/12 , C07D233/84 , C07D233/86 , C07D233/90 , C07D
Abstract: Compounds of the formula (I) in which R is, for example, ethyl, R is, for example, methyl, n is, for example, zero, R is, for example, COOH and R is, for example, SO2NHCONHCH3 are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:ZA919245B
公开(公告)日:1992-07-29
申请号:ZA919245
申请日:1991-11-22
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , ADALBERT WAGNER , HENNING RAINER , RAINER HENNING , NICKEL WOLF-ULRICH , WOLF-ULRICH NICKEL
IPC: A61K31/41 , A61K31/425 , A61P9/12 , A61P43/00 , C07D263/06 , C07D417/04 , C07D417/06 , C12N9/99 , C07D , A61K
Abstract: The invention relates to compounds of the formula in which W represents -CO-, -O-CO-, -SO2- or -NH-CO-, R , R , R , R , R and R represent hydrogen or an organic radical and R denotes alkyl, cycloalkyl or cycloalkylalkyl, processes for their preparation, intermediates and their use in the preparation of inhibitors of renin and HIV protease.
-
公开(公告)号:NO920048L
公开(公告)日:1992-07-06
申请号:NO920048
申请日:1992-01-03
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , ENGLERT HEINRICH , KLEEMANN HEINZ-WERNER , GERHARDS HERMANN , SCHOELKENS BERNWARD , BECKER REINHARD , LINZ WOLFGANG
IPC: A61K31/415 , A61K31/40 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00 , C07D233/64
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
44.
公开(公告)号:HU205770B
公开(公告)日:1992-06-29
申请号:HU250590
申请日:1990-04-20
Applicant: HOECHST AG
Inventor: NICKEL WOLF-ULRICH , LINZ WOLFGANG , RUPPERT DIETER , URBACH HANSJOERG , WAGNER ADALBERT
IPC: A61K38/55 , A61K38/00 , A61K38/05 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/06 , C07K5/065 , C07K14/81 , C07K5/02 , A61K37/64
Abstract: The present invention relates to compounds of the formula I in which A and B are, independently of one another, an amino acid, and W, R , R , R and R are as defined in the description, to processes for the preparation thereof, to the use thereof and to pharmaceutical compositions containing them.
-
45.
公开(公告)号:AU624579B2
公开(公告)日:1992-06-18
申请号:AU2295988
申请日:1988-09-29
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , KLEEMANN HEINZ-WERNER , RUPPERT DIETER , SCHOLKENS BERNWARD , URBACH HANSJORG
IPC: A61K38/55 , A61K38/00 , A61P9/12 , C07C67/00 , C07C231/00 , C07C237/06 , C07C237/08 , C07C237/14 , C07C237/20 , C07C237/22 , C07C273/10 , C07C301/00 , C07C303/22 , C07C303/40 , C07C309/14 , C07C309/70 , C07C313/00 , C07C317/48 , C07C323/60 , C07D413/06 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81 , C07K5/08 , A61K37/64 , C07D233/64 , C07D333/24 , C07D401/12 , C07D409/14
Abstract: The compounds have the formula in which R is absent or is hydrogen, alkyl or acyl, A is an acyl radical or an amino acid residue, B is an amino acid residue, R , R and R are as defined in the description, and R is -OH or -F, and they and their salts are used as pharmaceuticals.
-
公开(公告)号:NO914584L
公开(公告)日:1992-05-25
申请号:NO914584
申请日:1991-11-22
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , HENNING RAINER , NICKEL WOLF-ULRICH
IPC: A61K31/41 , A61K31/425 , A61P9/12 , A61P43/00 , C07D263/06 , C07D417/04 , C07D417/06 , C12N9/99 , C07D413/06
Abstract: The invention relates to compounds of the formula in which W represents -CO-, -O-CO-, -SO2- or -NH-CO-, R , R , R , R , R and R represent hydrogen or an organic radical and R denotes alkyl, cycloalkyl or cycloalkylalkyl, processes for their preparation, intermediates and their use in the preparation of inhibitors of renin and HIV protease.
-
公开(公告)号:ZA915683B
公开(公告)日:1992-04-29
申请号:ZA915683
申请日:1991-07-19
Applicant: HOECHST AG
Inventor: HENNING RAINER , RAINER HENNING , GERHARDS HERMANN , HERMANN GERHARDS , WAGNER ADALBERT , ADALBERT WAGNER , SCHOELKENS BERNWARD , BERNWARD SCHOELKENS
IPC: A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/425 , A61K31/44 , A61K31/495 , A61K31/505 , A61P1/16 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/12 , A61P43/00 , C07D233/56 , C07D233/90 , C07D403/10 , C07D413/10 , C07D417/10 , C07D417/12 , C07D471/04 , C07D473/00 , C07D487/04 , C07D498/04 , C07D513/04 , C07D , A61K
Abstract: Substd. azole derivs. of formula (I) and their physiologically acceptable salts are new. In (I) X, Y and Z are each N or CR2 R1 is 2-10C alkyl, 3-10C alkenyl, 3-10C alkynyl, -(CH2)mB(CH2nR4 (these 4 gps. opt. monosubstd. with CO2R3 and opt. have 1-all H atoms replaced by F), OR3, 3-8C cycloalkyl, 5-10C cycloalkylalkynyl, or benzyl (opt. mono or disubstd. on the Ph ring with halogen, 1-4C alkoxy and/or NO2), R2 = H, halogen, CvF2v+1, SF5, pentafluoro phenyl CN, phenyl, -(CH2)nF, -(CH2)nONO2, -CH2N3, -(CH2)nNO2, phthalimido (CH2)n-, R3 = H, 1-8C alkyl (in which 1 to all H are replaced by F), 3-8C cycloalkyl, Ph or benzyl, R4 = H, 1-6C alkyl, 3-8C cycloalkyl, 2-4C alkenyl, or 2-4C alkynyl, A = a mono or bicyclic unsatd. or partially hydrogenated heterocycle gp. with 5-10 ring atom of which up to 9 are C, and opt. substd. with up to 3 opt. different R14 gps. or -(CH2)n-1-(CHR6CH2)0-1, R14 where R14 = halogen, oxo, nitroso, NO2, amino, CN, OH, 1-6C alkyl, 1-4C alkanoyl, 1-4C alkanoyloxy. B = O, NR7 or S, W = O or S, L = 1-3C alkanediyl, R26 and R27 are each H, halogen, NO2, 1-4C alkyl or 1-2C alkoxy, n = 1-5, o = 1-10, q = 0-1.
-
48.
公开(公告)号:HU9200021D0
公开(公告)日:1992-03-30
申请号:HU9200021
申请日:1992-01-03
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , ENGLER HEINRICH , KLEEMANN HEINZ-WERNER , GERHARDS HERMANN , SCHOELKENS BERNWARD , BECKER REINHARD , LINZ WOLFGANG
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
49.
公开(公告)号:AU622014B2
公开(公告)日:1992-03-26
申请号:AU5371190
申请日:1990-04-23
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT , URBACH HANSJORG , RUPPERT DIETER , LINZ WOLFGANG , SCHOLKENS BERNWARD
IPC: A61K38/55 , A61K38/00 , A61P9/00 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81 , A61K37/64
Abstract: The present invention relates to compounds of the formula I in which A and B are, independently of one another, an amino acid, and R , R , R and R are as defined in the description, to processes for the preparation thereof, to their use as medicines and to pharmaceutical agents containing them.
-
公开(公告)号:AU8112991A
公开(公告)日:1992-01-23
申请号:AU8112991
申请日:1991-07-19
Applicant: HOECHST AG
Inventor: HENNING RAINER , WAGNER ADALBERT , GERHARDS HERMANN , SCHOLKENS VERNWARD
IPC: A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/425 , A61K31/44 , A61K31/495 , A61K31/505 , A61P1/16 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/12 , A61P43/00 , C07D233/56 , C07D233/90 , C07D403/10 , C07D413/10 , C07D417/10 , C07D417/12 , C07D471/04 , C07D473/00 , C07D487/04 , C07D498/04 , C07D513/04
Abstract: Substd. azole derivs. of formula (I) and their physiologically acceptable salts are new. In (I) X, Y and Z are each N or CR2 R1 is 2-10C alkyl, 3-10C alkenyl, 3-10C alkynyl, -(CH2)mB(CH2nR4 (these 4 gps. opt. monosubstd. with CO2R3 and opt. have 1-all H atoms replaced by F), OR3, 3-8C cycloalkyl, 5-10C cycloalkylalkynyl, or benzyl (opt. mono or disubstd. on the Ph ring with halogen, 1-4C alkoxy and/or NO2), R2 = H, halogen, CvF2v+1, SF5, pentafluoro phenyl CN, phenyl, -(CH2)nF, -(CH2)nONO2, -CH2N3, -(CH2)nNO2, phthalimido (CH2)n-, R3 = H, 1-8C alkyl (in which 1 to all H are replaced by F), 3-8C cycloalkyl, Ph or benzyl, R4 = H, 1-6C alkyl, 3-8C cycloalkyl, 2-4C alkenyl, or 2-4C alkynyl, A = a mono or bicyclic unsatd. or partially hydrogenated heterocycle gp. with 5-10 ring atom of which up to 9 are C, and opt. substd. with up to 3 opt. different R14 gps. or -(CH2)n-1-(CHR6CH2)0-1, R14 where R14 = halogen, oxo, nitroso, NO2, amino, CN, OH, 1-6C alkyl, 1-4C alkanoyl, 1-4C alkanoyloxy. B = O, NR7 or S, W = O or S, L = 1-3C alkanediyl, R26 and R27 are each H, halogen, NO2, 1-4C alkyl or 1-2C alkoxy, n = 1-5, o = 1-10, q = 0-1.
-
-
-
-
-
-
-
-
-